Polysaccharide of Atractylodes macrocephala Koidz alleviates LPS‐induced proliferation, differentiation inhibition and excessive apoptosis in chicken embryonic myogenic cells

Mengsi Fu, Jinhui Wang, Danning Xu, Nan Cao, Wanyan Li, Fada Li, Zhiyuan Liu, Yong Li, Chenyu Zhu, Yunmao Huang, Xumeng ZhangVeterinary 2024 · DOI

TL;DR

This study investigates how a traditional Chinese medicine component, Atractylodes macrocephala Koidz polysaccharide (PAMK), impacts chicken embryonic myogenic cells exposed to lipopolysaccharide (LPS), a common inflammatory trigger. PAMK effectively counteracts LPS-induced inflammation, impaired cell growth, and excessive cell death, suggesting its potential as a beneficial feed additive for poultry health.

What Problem Does This Paper Address?

Modern intensive farming practices can lead to environmental stressors that negatively affect poultry health and productivity. Lipopolysaccharide (LPS), a component of gram-negative bacteria, is a key trigger of systemic inflammation in poultry, leading to reduced growth and impaired immune responses. While LPS is known to cause inflammation and affect cell behavior, its specific impact on the proliferation, differentiation, and apoptosis of chicken embryonic myogenic cells (the precursors to muscle tissue) and how natural compounds might mitigate these effects remain areas needing further exploration. This paper aims to fill this gap by examining the protective role of PAMK, a component of the traditional Chinese medicine Atractylodes macrocephala, against LPS-induced damage in these crucial muscle cells.

Methods

The researchers utilized chicken embryonic myogenic cells as their model system. They employed a multi-pronged approach to assess the effects of LPS and PAMK, both individually and in combination, with and without belnacasan (a Caspase-1 inhibitor):

  • Cell Culture: Primary chicken embryonic myogenic cells were isolated and cultured.
  • EdU Immunofluorescence: This technique was used to quantify cell proliferation by detecting newly synthesized DNA.
  • Gene and Protein Expression Analysis: Real-time quantitative PCR (RT-qPCR) was used to measure mRNA levels of genes related to inflammation (TNFα, IL6, IL1β), proliferation (IGF1, MyoD), differentiation (Myh1, Myog, MSTN), and apoptosis (Caspase1, Caspase3, Bcl2). Western blotting was employed to assess the protein levels of key inflammatory markers (TNFα, IL6) and muscle development proteins (MyoD, MYHC, MSTN).
  • Apoptosis Assays: Fluorescence-activated cell sorting (FACS) was used to quantify apoptotic cells, and the expression of apoptosis-related genes was analyzed.
  • Immunofluorescence Staining: Myosin Heavy Chain (MYHC) immunofluorescence was used to assess myotube differentiation and myofiber diameter.

Datasets

Not discussed in the paper. The study used primary cell cultures derived from chicken embryos.

Key Insights and Ideas

  • LPS as a Disruptor: LPS significantly triggers inflammatory responses, inhibits the proliferation and differentiation of chicken embryonic myogenic cells, and leads to excessive apoptosis. This confirms LPS's detrimental role in muscle development.
  • PAMK's Protective Shield: PAMK demonstrates a remarkable ability to counteract the negative effects of LPS. It alleviates inflammation, promotes cell proliferation and differentiation, and reduces LPS-induced apoptosis.
  • The Role of Caspase-1: The study highlights the involvement of Caspase-1 in LPS-induced apoptosis. Inhibiting Caspase-1 with belnacasan reduced apoptosis, but it also partially mitigated the beneficial effects of PAMK, suggesting a complex interplay.
  • Mechanism of Action: The findings suggest that PAMK's protective effects against LPS may involve modulating inflammatory pathways, supporting myogenic gene expression, and regulating apoptotic machinery.

Key Results

  • Inflammation: LPS significantly increased the mRNA and protein expression of inflammatory factors (TNFα, IL6, IL1β). PAMK treatment significantly reduced these increases.
  • Proliferation: LPS treatment significantly decreased the EdU-positive rate (a measure of proliferation) in myogenic cells. PAMK treatment, especially in combination with LPS, helped restore proliferation levels.
  • Differentiation: LPS treatment reduced the differentiation index and myofiber diameter. PAMK treatment, in combination with LPS, improved these differentiation markers.
  • Apoptosis: LPS significantly increased the number of apoptotic cells and the expression of pro-apoptotic genes (Caspase1, Caspase3). PAMK treatment significantly reduced apoptosis.
  • Belnacasan's Influence: While belnacasan (Caspase-1 inhibitor) reduced apoptosis, its effect on proliferation and differentiation was less pronounced than PAMK's, and in some cases, it seemed to counteract PAMK's benefits.

Limitations and Future Work

The authors acknowledge that while their study provides a theoretical basis for PAMK's action, the specific molecular mechanisms require further in-depth investigation. They suggest that future research should focus on elucidating these detailed pathways. Additionally, the study was conducted in vitro using cell cultures, and in vivo studies in live poultry would be necessary to validate these findings and assess the practical application of PAMK as a feed additive. The complex interplay between apoptosis and proliferation, particularly in the context of belnacasan's effects, also warrants further exploration.

Summary updated

Abstract

This study provides a theoretical basis for further exploring the mechanism of action of PAMK and exogenous LPS on chicken embryonic myogenic cells and lays the foundation for the development and application of green feed additives in animal husbandry industry.
BibTeX
@inproceedings{fu2024polysaccharide,
  author = {Mengsi Fu and Jinhui Wang and Danning Xu and Nan Cao and Wanyan Li and Fada Li and Zhiyuan Liu and Yong Li and Chenyu Zhu and Yunmao Huang and Xumeng Zhang},
  title = {{Polysaccharide of <i>Atractylodes macrocephala</i> Koidz alleviates LPS‐induced proliferation, differentiation inhibition and excessive apoptosis in chicken embryonic myogenic cells}},
  booktitle = {Veterinary},
  year = {2024},
  doi = {10.1002/vms3.1412},
}
Figure